UNCY (Unicycive Therapeutics, Inc.) Stock Market Reviews

crown

search

Read and share opinions on UNCY (Unicycive Therapeutics, Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock ma

UNCY

Unicycive Therapeutics, Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Unicycive Therapeutics to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference
Nov 3, 2025
Unicycive Therapeutics Announces Upcoming Presentation of New Data Reinforcing the Potential of Oxylanthanum Carbonate for the Treatment of Hyperphosphatemia at the American Society of Nephrology Kidney Week 2025 Conference
Oct 30, 2025
Unicycive Therapeutics Provides Update from FDA Type A Meeting and Expects to Resubmit OLC NDA Before Year-End
Oct 28, 2025
When Will Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Turn A Profit?
Oct 14, 2025
Unicycive Therapeutics to Participate in Upcoming Investor Events in September
Aug 26, 2025
Unicycive Therapeutics Granted New U.S. Patent for UNI-494 to Treat Chronic Kidney Disease
Aug 18, 2025
Unicycive Therapeutics Announces the Publication of Oxylanthanum Carbonate Pivotal Trial Data in Clinical Journal of the American Society of Nephrology
Jul 24, 2025
Unicycive Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
Jul 8, 2025
Unicycive Therapeutics to Present at the H.C. Wainwright 4th Annual Kidney Virtual Conference
Jul 7, 2025
Unicycive Therapeutics, Inc. Announces Reverse Stock Split
Jun 17, 2025
Unicycive Provides Update on New Drug Application for Oxylanthanum Carbonate to Treat Hyperphosphatemia in Patients with Chronic Kidney Disease on Dialysis
Jun 10, 2025
Unicycive Therapeutics to Present at Upcoming Investor Conferences
May 22, 2025
Unicycive Therapeutics Announces Time Change for 2025 Annual Meeting of Stockholders
May 21, 2025
Analysts Expect Breakeven For Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Before Long
May 7, 2025

Reviews